Enhanced Genomics
British BioTech company innovating 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases
Cambridge, UKenhancedgenomics.com ↗
Total raised
€16M
€16,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-17 | Series A | €16M | BGF,Meltwind,Parkwalk | View deal → |